EntryPoint Capital’s Oracle ORCL Stock Holding History

EntryPoint Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,108	Closed	-$117K	–	1663
2023 Q4	$117K	Buy	+1,108	New	+$121K	0.11%	304

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EntryPoint Capital's ORCL Position: Q1 2024 in Review

EntryPoint Capital sold out of Oracle (ORCL) in Q1 2024, closing a stake of 1,108 shares — an estimated $117K sold.

EntryPoint Capital first reported a position in ORCL in Q4 2023 and held it in 1 quarter. The position peaked at $117K in Q4 2023. 2,811 funds tracked by Wall St. Rank hold ORCL as of Q1 2024.

EntryPoint Capital reported no remaining Oracle position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 1,108 Oracle shares in Q1 2024, an estimated $117K.
EntryPoint Capital first reported a position in Oracle in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's Oracle position peaked at $117K in Q4 2023.
2,811 funds tracked by Wall St. Rank held Oracle as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.